Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind CKBA cream trial in papulopustular rosacea
CTR20263259Phase 2Active
- Sponsor
- Bochuangyuan Biopharmaceutical
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid in papulopustular rosacea, sponsored by Bochuangyuan Biopharmaceutical. Started Aug 2026; status: active.
02
Drugs
3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on CTR20263259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263259.